✦ LIBER ✦

P-333 An economic evaluation of different chemotherapy regimensused in the treatment of advanced non-small cell lung cancer

✍ Scribed by Massuti, B.; Burgos, A.; Martí Ciriquián, J.; Llinares, F.; Montoyo, R.; Pena, E.; Yuste, A.; Gil, J.; Romero, S.; Ordovas, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy without cisplat

✍ Pujol, Jean-Louis; Quantin, Xavier; Choma, Didier; Jacot, William; Khial, Farid 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Advances in the treatment of non-small c

✍ Nagahiro Saijo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Ifosfamide, cisplatin, vinblastine combi

✍ Hiroshi Saito; Kaoru Shimokata; Masashi Yamamoto; Hideo Saka; Shuzo Sakai; Hidea 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 214 KB

Ifosfamide, cisplatin, vinblastine combi

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 321 KB

State-of-the-art chemotherapy for advanc

✍ Sakkaraiappan Ramalingam; Chandra P Belani 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 87 KB

CN2 ECONOMIC EVALUATION OF EGFR-GUIDEDTR

✍ JJ Carlson; L Garrison; S Ramsey; DL Veenstra 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB